About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT03048409

Retrospective Tube Feeding Tolerance in Adults With Intolerance After Switch to a Peptide-Based Formula

A retrospective chart review to assess feeding tolerance in adults who had been switched from an intact protein formula to a peptide-based formula due to feeding intolerance in a complex continuing ca...

Lead sponsor: Société des Produits Nestlé (SPN)•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Société des Produits Nestlé (SPN)

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•\> 18 years of age on admission to facility
•Prescribed enteral nutrition with the goal to provide at least 90% of estimated daily calorie and protein requirements for ≥ 2 weeks prior to switch
•Received enteral nutrition with an intact protein formula for a minimum of three days prior to a switch to a peptide-based formula
•Have documentation of intolerance to an intact protein formula, followed by a switch in formula received to a peptide-based formula
•Receiving a peptide-based formula formula for ≥ 2 weeks
•Have documentation of an assessment of feeding tolerance following the switch
•Formulas received must be indicated for use in adults.

Exclusion Criteria

•Abdominal surgery (within past 30 days prior to switch)
•Having any infection, including upper respiratory, viral, gastroenteritis,wound infections, c difficile, at time of switch
•Having documented cow's milk protein allergy at time of switch
•Medical records lacking information on rationale for switch to a peptide-based formula and/or response to change (positive, neutral or negative).

Related studies

Bedside Observation by Clinical Ultrasound for Stomach Expansion

NCT07312890 · Enteral Feeding Intolerance

Enteral Nutrition Tolerance and the Gut Microbiome Study

NCT03795870 · Enteral Feeding Intolerance

WITHDRAWNPhase 3

Efficacy and Safety of Numeta G13%E Compared to Compounded Parenteral Nutrition in Preterm Neonates

NCT06894446 · Malnutrition, Infant, Enteral Feeding Intolerance

Early Total Enteral Feeding Versus Convention Enteral Feeding in Preterm Infants 27-32 Weeks of Gestation

NCT06076460 · Very Preterm Maturity of Infant, Enteral Feeding Intolerance

COMPLETEDPhase 1/2

The Effect of Prucalopride on Gastric Emptying in Intensive Care Unit Patients

NCT05496179 · Enteral Feeding Intolerance

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 12, 2019Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment10

Start dateJul 2017

Last updatedJul 12, 2019

Condition

Enteral Feeding Intolerance

Locations shown

Bruyere Research Institute

Ottawa, Ontario

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 12, 2019Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions